CLINICAL AND LABORATORY VARIABLES THAT PREDICT CLINICAL AND ENDOSCOPIC REMISSION IN CHILDREN WITH CROHN’S DISEASE TREATED WITH INFLIXIMAB

(1) Sapienza University of Rome,Pediatric Gastroenterology and Liver Unit,ROME,Italy



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)